Position in GILD
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$755,765
+$91,528 QoQ
Shares Held
5,982
+25.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#1,200
of 2,265 holders
Holding Since
Dec 2023
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Balefire, LLC holds $12,645,380 across 10 Drug Manufacturers - General names. GILD ranks #7 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,262 | $5,111,971 | |
| 2 | JNJ |
Johnson & Johnson
|
5,701 | $1,447,882 | |
| 3 | MRK |
Merck & Co., Inc.
|
10,039 | $1,290,011 | |
| 4 | AMGN |
Amgen Inc
|
3,296 | $1,193,547 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
18,299 | $1,054,388 | |
| 6 | ABBV |
AbbVie Inc.
|
3,997 | $1,005,805 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
5,982 | $755,765 | |
| 8 | AZN |
Astrazeneca PLC
|
1,645 | $311,924 |
All Filings in GILD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $755,765 | 5,982 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $664,237 | 4,766 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $801,123 | 6,527 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $538,905 | 4,855 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $483,836 | 4,364 | Shares | Sole | 2025-07-09 | |
| 2024-03-31 | $2,124 | 29 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,349 | 29 | Shares | Sole | 2024-02-07 | |
| No filing history on record for this holder in this stock. | ||||||